Enzyme Immunoassay Market 2026 Market Size And Growth Forecast: Key Trends To Watch
Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
Enzyme Immunoassay Market Size, Value And Growth Trajectory Through 2030
The enzyme immunoassay market has experienced strong expansion in recent years. It is anticipated to increase from $21.5 billion in 2025 to $23.09 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.4%. The historical growth in this sector can be attributed to factors such as the limited availability of automated EIA systems, the reliance on manual microplate readers, the development of clinical laboratory infrastructure, the rising prevalence of chronic and infectious diseases, and the adoption of conventional reagents and kits.
The enzyme immunoassay market is set for significant expansion over the next few years, with projections indicating a rise to $30.37 billion by 2030, achieving a compound annual growth rate (CAGR) of 7.1%. This growth during the forecast period can be attributed to advancements like the development of fully automated EIA analyzers, the broadening scope of personalized medicine and precision diagnostics, increased integration of laboratory information systems, the growing embrace of software and data analysis tools, and heightened demand from academic and research institutions. Key trends anticipated in this period include the increasing adoption of automated EIA analyzers, an uptick in therapeutic drug monitoring applications, wider utilization of multiplex testing and high-throughput assays, the expansion of oncology and infectious disease testing, and an improved focus on laboratory data integration and workflow efficiency.
Get A Free Sample Report With In-Depth Market Insights:
Enzyme Immunoassay Market Expansion Drivers: What’s Shaping Future Growth?
The enzyme immunoassay market is projected to expand due to the escalating challenge posed by infectious diseases. These illnesses, caused by harmful microorganisms like bacteria, viruses, fungi, or parasites, are transmissible among individuals. The increasing severity of infectious diseases stems from antimicrobial resistance, which complicates the treatment of common infections, leading to prolonged sickness, elevated medical costs, and higher mortality rates. Enzyme immunoassays are essential for diagnosing infectious diseases as they enable the sensitive and specific detection of antigens or antibodies in patient samples, facilitating prompt identification, effective monitoring, and timely treatment of infections such as HIV, hepatitis, and influenza. For instance, in April 2025, the Minnesota Department of Health, a US-based government agency, reported that the proportion of HIV cases among males aged 35 to 39 increased from 10% in 2023 to 17% in 2024, demonstrating a significant rise in this age group’s share of total cases. Consequently, the rising burden of infectious diseases is stimulating the growth of the enzyme immunoassay market.
Enzyme Immunoassay Market Segment Trends And Revenue Contributors
The enzyme immunoassay market covered in this report is segmented –
1) By Product: Reagents And Kits, Analyzers Or Instruments, Software And Services
2) By Specimen: Blood, Saliva, Urine, Other Specimens
3) By Application: Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications
4) By End-Use: Hospitals, Blood Banks, Clinical Laboratories, Pharmaceutical And Biotech Companies, Academic Research Centers, Other End-Uses
Subsegments:
1) By Reagents And Kits: Antibodies, Antigens, Substrates, Buffers And Stabilizers
2) By Analyzers Or Instruments: Fully Automated EIA Analyzers, Semi-Automated EIA Systems, Microplate Readers, Washers And Incubators
3) By Software And Services: Data Analysis And Interpretation Software, Laboratory Information System Integration Tools, Instrument Calibration And Validation Services, Technical Support And User Training
Enzyme Immunoassay Market Strategic Trends: What Defines The Next Growth Phase?
Leading companies in the enzyme immunoassay market are concentrating on bringing forth innovative enzyme immunoassay (EIA) solutions, such as fully automated enzyme immunoassays, to elevate diagnostic precision, diminish manual errors, and bolster workflow efficiency in clinical laboratories. Fully automated enzyme immunoassays are defined as diagnostic systems that execute the entire testing process autonomously, consequently boosting speed, accuracy, and consistency in laboratory results. For instance, in July 2024, Fujirebio Holdings Inc., a Japan-based in vitro diagnostics (IVD) company, unveiled the fully automated Lumipulse G GFAP assay for research use only (RUO), thereby expanding its neuro-biomarker portfolio. This RUO chemiluminescent enzyme immunoassay measures glial fibrillary acidic protein (GFAP) in human plasma and serum utilizing the LUMIPULSE G platform and yields results in just 35 minutes. It functions as an astrocytic biomarker associated with conditions like multiple sclerosis, Alzheimer’s and Parkinson’s diseases, stroke, and traumatic brain injury. This assay further enhances Fujirebio’s expanding neuro menu, which currently features NfL, pTau217, and sTREM2, enabling comprehensive neurodegenerative disease profiling on a single automated system.
Enzyme Immunoassay Market Leading Players And Competitive Positioning
Major companies operating in the enzyme immunoassay market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Danaher Corporation, Merck KGaA, Siemens Healthineers AG, Becton Dickinson and Company (BD), PerkinElmer Inc., BioMérieux SA, Bio-Rad Laboratories Inc., Diasorin S.p.A., Bio-Techne Corporation, Quidel Corporation, Promega Corporation, Abcam plc, BioLegend Inc., Helena Laboratories Corporation, Cayman Chemical Company, Enzo Life Sciences Inc., RayBiotech Inc., MyBioSource Inc., Boster Biological Technology, Hycult Biotech, Calbiotech Inc.
View The Full Enzyme Immunoassay Market Report:
Enzyme Immunoassay Market Regional Distribution: Which Areas Power Market Growth?
North America was the largest region in the enzyme immunoassay market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the enzyme immunoassay market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
